Unlike breast and gastric cancers, a specific scoring system for defining HER2 positivity in CRC was not been completely established until the introduction of the HERACLES (HER2 Amplification for Colorectal Cancer Enhanced Stratification) criteria. The gene discussed is ERBB2; the disease is colorectal cancer.